iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
iRhythm Technologies (NASDAQ:IRTC), a digital healthcare company specializing in disease detection and prediction solutions, has scheduled its Q2 2025 earnings release for July 31, 2025, after market close.
The company will host a conference call at 1:30 PM PT / 4:30 PM ET on the same day. Investors can access both the live and archived versions of the webcast through the "Quarterly Results" section on iRhythm's investor relations website at investors.irhythmtech.com.
iRhythm Technologies (NASDAQ:IRTC), un'azienda di sanità digitale specializzata in soluzioni per la rilevazione e previsione delle malattie, ha programmato la pubblicazione dei risultati del secondo trimestre 2025 per il 31 luglio 2025, dopo la chiusura del mercato.
La società terrà una conference call alle 13:30 PT / 16:30 ET dello stesso giorno. Gli investitori potranno accedere sia alla diretta che alla registrazione del webcast tramite la sezione "Quarterly Results" sul sito delle relazioni con gli investitori di iRhythm, disponibile su investors.irhythmtech.com.
iRhythm Technologies (NASDAQ:IRTC), una empresa de salud digital especializada en soluciones para la detección y predicción de enfermedades, ha programado la publicación de sus resultados del segundo trimestre de 2025 para el 31 de julio de 2025, después del cierre del mercado.
La compañía realizará una llamada conferencia a las 1:30 PM PT / 4:30 PM ET ese mismo día. Los inversores podrán acceder tanto a la transmisión en vivo como a la grabación del webcast a través de la sección "Quarterly Results" en el sitio web de relaciones con inversionistas de iRhythm en investors.irhythmtech.com.
iRhythm Technologies (NASDAQ:IRTC)는 질병 감지 및 예측 솔루션을 전문으로 하는 디지털 헬스케어 회사로, 2025년 2분기 실적 발표를 2025년 7월 31일 시장 마감 후에 예정했습니다.
회사는 같은 날 오후 1:30 PT / 오후 4:30 ET에 컨퍼런스 콜을 진행합니다. 투자자들은 iRhythm의 투자자 관계 웹사이트인 investors.irhythmtech.com의 "Quarterly Results" 섹션을 통해 생중계 및 녹화된 웹캐스트를 모두 시청할 수 있습니다.
iRhythm Technologies (NASDAQ:IRTC), une entreprise de santé numérique spécialisée dans les solutions de détection et de prédiction des maladies, a programmé la publication de ses résultats du deuxième trimestre 2025 pour le 31 juillet 2025, après la clôture des marchés.
La société tiendra une conférence téléphonique à 13h30 PT / 16h30 ET le même jour. Les investisseurs pourront accéder à la fois à la diffusion en direct et à l'enregistrement du webcast via la section "Quarterly Results" sur le site des relations investisseurs d’iRhythm à l’adresse investors.irhythmtech.com.
iRhythm Technologies (NASDAQ:IRTC), ein digitales Gesundheitsunternehmen, das sich auf Lösungen zur Krankheitsdetektion und -vorhersage spezialisiert hat, hat die Veröffentlichung der Ergebnisse für das zweite Quartal 2025 für den 31. Juli 2025 nach Börsenschluss geplant.
Das Unternehmen wird am selben Tag um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz abhalten. Investoren können sowohl die Live-Übertragung als auch die Aufzeichnung des Webcasts über den Bereich "Quarterly Results" auf der Investor-Relations-Webseite von iRhythm unter investors.irhythmtech.com abrufen.
- None.
- None.
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2025 after the close of trading on Thursday, July 31, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com
Media Contact
Kassandra Perry
irhythm@highwirepr.com
FAQ
When will iRhythm Technologies (IRTC) report Q2 2025 earnings?
What time is iRhythm's Q2 2025 earnings conference call?
How can investors access iRhythm's Q2 2025 earnings call?
What does iRhythm Technologies (IRTC) do?
